The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
An amphetamine in which the parent 1-phenylpropan-2-amine skeleton is substituted at position 1 with an hydroxy group. A decongestant and appetite suppressant, it is commonly used in prescription and over-the-counter cough and cold preparations.
Enzyme Inhibitors inhibits the reaction [Phenylpropanolamine results in increased expression of CAT protein]; S-ethyl glutathione inhibits the reaction [Phenylpropanolamine results in increased expression of CAT mRNA]; STAT3 mRNA promotes the reaction [Phenylpropanolamine results in increased expression of CAT mRNA] Phenylpropanolamine results in increased expression of CAT mRNA; Phenylpropanolamine results in increased expression of CAT protein
Phenylpropanolamine results in increased expression of CREB1 mRNA Phenylpropanolamine results in increased expression of and results in increased activity of CREB1 protein
Enzyme Inhibitors inhibits the reaction [Phenylpropanolamine results in increased expression of GSTA1 protein]; S-ethyl glutathione inhibits the reaction [Phenylpropanolamine results in increased expression of GSTA1 mRNA]; STAT3 mRNA promotes the reaction [Phenylpropanolamine results in increased expression of GSTA1 mRNA] Phenylpropanolamine results in increased expression of GSTA1 mRNA; Phenylpropanolamine results in increased expression of GSTA1 protein
Phenylpropanolamine inhibits the reaction [MAOA protein results in increased degradation of Serotonin] Phenylpropanolamine results in decreased activity of MAOA protein Phenylpropanolamine inhibits the reaction [Clorgyline results in decreased activity of MAOA protein]
Phenylpropanolamine results in decreased activity of MAOB protein Phenylpropanolamine inhibits the reaction [MAOB protein results in increased degradation of phenethylamine]
[Prazosin co-treated with SCH 23390] inhibits the reaction [Phenylpropanolamine results in decreased expression of NPY protein]; Enzyme Inhibitors inhibits the reaction [Phenylpropanolamine results in decreased expression of NPY protein]; NPY1R protein affects the reaction [Phenylpropanolamine results in decreased expression of NPY protein]; S-ethyl glutathione inhibits the reaction [Phenylpropanolamine results in decreased expression of NPY mRNA]; STAT3 mRNA promotes the reaction [Phenylpropanolamine results in decreased expression of NPY mRNA] Phenylpropanolamine results in decreased expression of NPY mRNA; Phenylpropanolamine results in decreased expression of NPY protein
NPY1R protein affects the reaction [Phenylpropanolamine results in decreased expression of NPY protein] Phenylpropanolamine results in increased expression of NPY1R protein NPY1R protein affects the susceptibility to Phenylpropanolamine
Phenylpropanolamine results in increased expression of POMC mRNA; Phenylpropanolamine results in increased expression of POMC protein S-ethyl glutathione inhibits the reaction [Phenylpropanolamine results in increased expression of POMC mRNA]; STAT3 mRNA promotes the reaction [Phenylpropanolamine results in increased expression of POMC mRNA]
Enzyme Inhibitors inhibits the reaction [Phenylpropanolamine results in increased expression of SOD1 protein]; S-ethyl glutathione inhibits the reaction [Phenylpropanolamine results in increased expression of SOD1 mRNA]; STAT3 mRNA promotes the reaction [Phenylpropanolamine results in increased expression of SOD1 mRNA] Phenylpropanolamine results in increased expression of SOD1 mRNA; Phenylpropanolamine results in increased expression of SOD1 protein
Enzyme Inhibitors inhibits the reaction [Phenylpropanolamine results in increased expression of STAT3 protein modified form]; S-ethyl glutathione inhibits the reaction [Phenylpropanolamine results in increased expression of STAT3 mRNA]; STAT3 mRNA promotes the reaction [Phenylpropanolamine results in decreased expression of NPY mRNA]; STAT3 mRNA promotes the reaction [Phenylpropanolamine results in increased expression of CAT mRNA]; STAT3 mRNA promotes the reaction [Phenylpropanolamine results in increased expression of GSTA1 mRNA]; STAT3 mRNA promotes the reaction [Phenylpropanolamine results in increased expression of POMC mRNA]; STAT3 mRNA promotes the reaction [Phenylpropanolamine results in increased expression of SOD1 mRNA] STAT3 mRNA results in increased susceptibility to Phenylpropanolamine Phenylpropanolamine results in increased activity of STAT3 protein Phenylpropanolamine results in increased expression of STAT3 mRNA; Phenylpropanolamine results in increased expression of STAT3 protein modified form